RAPT Therapeutics, Inc. — Form D/A

RAPT Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2019-06-20. The offering totals $67.1M, of which $37.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
David V GoeddelDirectorSouth San Francisco, CA
Beth V SeidenbergDirectorSouth San Francisco, CA
Eric F HallExecutive OfficerSouth San Francisco, CA
Paul F KassnerExecutive OfficerSouth San Francisco, CA
David F WustrowExecutive OfficerSouth San Francisco, CA
Beth SeidenbergDirectorSouth San Francisco, CA
Rodney J YoungExecutive OfficerSouth San Francisco, CA
Lori V Lyons-WilliamsDirectorSouth San Francisco, CA
Wendye J RobbinsDirectorSouth San Francisco, CA
Dirk J BrockstedtExecutive OfficerSouth San Francisco, CA
Linda J KozickDirectorSouth San Francisco, CA
William J HoExecutive OfficerSouth San Francisco, CA
Brian WongDirectorSan Francisco, CA
Brian WongExecutive OfficerSan Francisco, CA
William J RieflinDirectorSouth San Francisco, CA
Michael GiordanoDirectorSouth San Francisco, CA
Mary Ann V GrayDirectorSouth San Francisco, CA
David GoeddelDirectorAgoura Hills, CA
Dirk F BrockstedtExecutive OfficerSouth San Francisco, CA
Michael F GiordanoDirectorSouth San Francisco, CA
Wendye F RobbinsDirectorSouth San Francisco, CA
William F HoExecutive OfficerSouth San Francisco, CA
Rekha J HemrajaniExecutive OfficerSouth San Francisco, CA
Tim J LinExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2025-01-03D$150.0M$150.0M
2022-06-03D$50.0M$50.0M
2019-01-02D$35.0M$22.6M
2018-01-04D$59.9M$29.9M
2016-05-05D$50.0M$50.0M

More